Panbela Therapeutics Média de recomendação
Qual é o Média de recomendação de Panbela Therapeutics?
O Média de recomendação de Panbela Therapeutics Inc. é 2.50
Qual é a definição de Média de recomendação?
A média da recomendação é a média das classificações dos analistas das ações, variando de 1,0 (compra forte) a 5,0 (venda forte).
Mean of recommendations is an average of ratings from different analysts but it should still be used with other research and investment metrics in order to make investment decisions. It is important to understand a firm's entire scale when assimilating ratings. Additionally, analyst recommendations on stocks owned by firms employing them may be seen as potentially biased.
Financial analysts are often employed by mutual and pension funds, hedge funds, securities firms, banks, investment banks, insurance companies, and other businesses, helping these companies or their clients make investment decisions. Financial analysts employed in commercial lending perform "balance sheet analysis," examining the audited financial statements and corollary data in order to assess lending risks. In a stock brokerage house or in an investment bank, they read company financial statements and analyze commodity prices, sales, costs, expenses, and tax rates in order to determine a company's value and project future earnings. In any of these various institutions, the analyst often meets with company officials to gain a better insight into a company's prospects and to determine the company's managerial effectiveness.
Usually, financial analysts study an entire industry, assessing current trends in business practices, products, and industry competition. They must keep abreast of new regulations or policies that may affect the industry, as well as monitor the economy to determine its effect on earnings.
Média de recomendação de empresas na Setor Health Care em NASDAQ em comparação com Panbela Therapeutics
O que Panbela Therapeutics faz?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Empresas com média de recomendação semelhantes a Panbela Therapeutics
- Revvity tem Média de recomendação de 2.47
- Cardinal Health tem Média de recomendação de 2.47
- Cintas tem Média de recomendação de 2.47
- Textron tem Média de recomendação de 2.47
- Ralph Lauren Corp tem Média de recomendação de 2.48
- NOV Inc tem Média de recomendação de 2.48
- Panbela Therapeutics tem Média de recomendação de 2.50
- Landbridge tem Média de recomendação de 2.52
- Urban Outfitters tem Média de recomendação de 2.52
- Wells Fargo & Co tem Média de recomendação de 2.52
- United Airlines Inc tem Média de recomendação de 2.52
- Cognizant Technology Solutions tem Média de recomendação de 2.52
- Grupo Aeroportuario Del Pacifico SAB de CV tem Média de recomendação de 2.53